Showing results (51-60 of 75) with videos related to
Sort By:
Pageof 8
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 7, 2026
Risk stratification of a novel non-invasive fibrosis score in metabolic dysfunction-associated steatotic liver diseaseJohnny T K Cheung, Xinsrong Zhang, Grace Lai-Hung Wong, et al.Alimentary Pharmacology & Therapeutics|September 19, 2023
MAFLD fibrosis score: Using routine measures to identify advanced fibrosis in metabolic-associated fatty liver diseaseJohnny T K Cheung, Xinrong Zhang, Grace Lai-Hung Wong, et al.Alimentary Pharmacology & Therapeutics|February 23, 2023
Trends in risk factor control and treatment among patients with non-alcoholic fatty liver disease and type 2 diabetes between 2000 and 2020: A territory-wide studyXinrong Zhang, Terry Cheuk-Fung Yip, Yee-Kit Tse, et al.Alimentary Pharmacology & Therapeutics|February 2, 2024
Machine learning improves the prediction of significant fibrosis in Asian patients with metabolic dysfunction-associated steatotic liver disease - The Gut and Obesity in Asia (GO-ASIA) StudyNipun Verma, Ajay Duseja, Manu Mehta, et al.JHEP Reports : Innovation in Hepatology|August 4, 2023
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver diseaseGrazia Pennisi, Marco Enea, Mauro Viganò, et al.Journal of Hepatology|June 23, 2025
Impact of first and further decompensation in patients with compensated ACLD due to MASLDGrazia Pennisi, Gabriele Di Maria, Vincent Wai-Sun Wong, et al.JAMA|March 21, 2024
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver DiseaseHuapeng Lin, Hye Won Lee, Terry Cheuk-Fung Yip, et al.Journal of Hepatology|January 25, 2025
Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver diseaseTerry Cheuk-Fung Yip, Hye Won Lee, Huapeng Lin, et al.Hepatology (Baltimore, Md.)|December 26, 2025
Head-to-head comparison between vibration-controlled transient elastography and histology in predicting liver-related events due to metabolic dysfunction-associated steatotic liver diseaseYangyue Zhang, Hye Won Lee, Huapeng Lin, et al.Clinical and Molecular Hepatology|November 11, 2025
Histological severity and hepatic outcomes in patients with MASLD and discrepant FIB-4 and liver stiffness measurementJoseph Rabbat, Boyu Yang, Hye Won Lee, et al.Pageof 8